HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -7.22% | -25.95% | -36.01% | -28.56% | 7.24% |
| Total Depreciation and Amortization | -31.19% | -18.61% | -26.86% | -31.57% | -40.73% |
| Total Amortization of Deferred Charges | -21.08% | -12.21% | -5.37% | -2.63% | 8.42% |
| Total Other Non-Cash Items | 1,404.65% | 435.98% | 179.87% | 187.58% | -94.49% |
| Change in Net Operating Assets | 75.75% | 85.54% | 84.59% | 78.73% | 47.87% |
| Cash from Operations | 6.98% | -11.50% | -18.63% | -15.38% | -8.25% |
| Capital Expenditure | 96.23% | 96.42% | 87.74% | -11.11% | -5.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.64% | 304.95% | 432.98% | 279.60% | -83.50% |
| Cash from Investing | 130.48% | 286.36% | 384.00% | 256.75% | -87.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -255.89% | -915.96% | -782.63% | -326.61% | 82.01% |
| Issuance of Common Stock | -25.90% | 42.67% | -42.20% | -45.57% | -9.19% |
| Repurchase of Common Stock | -5,301.96% | -16,836.36% | -14,615.79% | -7,535.29% | -24.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.13% | -4.32% | 26.62% | 30.49% | 32.48% |
| Cash from Financing | -81.67% | -17.19% | -92.87% | -70.43% | -26.42% |
| Foreign Exchange rate Adjustments | 112.00% | 60.87% | -1,140.00% | -377.38% | -214.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.19% | 120.40% | 18.92% | -5.13% | -188.39% |
